AG-73305

· Allgenesis Biotherapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AG-73305, covering 2025-10-15 to 2025-10-15. Get the full timeline:

Most recent: Clinical Trial Update: A Single Ascending Dose Cohort Study of AG-73305 in DME Patients [Phase 2]